Literature DB >> 11895805

Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia.

Heather N Crans-Vargas1, Elliot M Landaw, Smita Bhatia, George Sandusky, Theodore B Moore, Kathleen M Sakamoto.   

Abstract

Cyclic adenosine monophosphate response-element binding protein (CREB) is a nuclear protein that regulates expression of genes that control cell proliferation, differentiation, and survival. To analyze CREB expression in leukemia cells, we conducted Western blot analysis of bone marrow cells obtained from patients with acute lymphoblastic leukemia, patients with acute myeloid leukemia, and patients without active leukemia. CREB was expressed at a higher frequency in bone marrow cells from patients with acute lymphoid or myeloid leukemia than in patients with leukemia remission or without leukemia. Our results indicate that CREB expression could be a useful marker for leukemia in patients with acute disease and suggest a role for CREB in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895805     DOI: 10.1182/blood.v99.7.2617

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Targeting CREB for cancer therapy: friend or foe.

Authors:  Xiangshu Xiao; Bingbing X Li; Bryan Mitton; Alan Ikeda; Kathleen M Sakamoto
Journal:  Curr Cancer Drug Targets       Date:  2010-06       Impact factor: 3.428

2.  Sox4 cooperates with CREB in myeloid transformation.

Authors:  Salemiz Sandoval; Christina Kraus; Er-Chieh Cho; Michelle Cho; Juraj Bies; Elena Manara; Benedetta Accordi; Elliot M Landaw; Linda Wolff; Martina Pigazzi; Kathleen M Sakamoto
Journal:  Blood       Date:  2012-05-24       Impact factor: 22.113

3.  Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.

Authors:  In-Kyu Kim; Justine N McCutcheon; Guanhua Rao; Stephen V Liu; Yves Pommier; Marcin Skrzypski; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

Review 4.  CREB and leukemogenesis.

Authors:  Er-Chieh Cho; Bryan Mitton; Kathleen M Sakamoto
Journal:  Crit Rev Oncog       Date:  2011

5.  Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.

Authors:  Sita Aggarwal; Seung-Wook Kim; Seung-Hee Ryu; Wen-Cheng Chung; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

6.  Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Authors:  Hye-Sook Seo; Diane D Liu; B Nebiyou Bekele; Mi-Kyoung Kim; Katherine Pisters; Scott M Lippman; Ignacio I Wistuba; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

7.  Expression profile of CREB knockdown in myeloid leukemia cells.

Authors:  Matteo Pellegrini; Jerry C Cheng; Jon Voutila; Dejah Judelson; Julie Taylor; Stanley F Nelson; Kathleen M Sakamoto
Journal:  BMC Cancer       Date:  2008-09-18       Impact factor: 4.430

8.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

9.  Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB Inhibitor.

Authors:  Bingbing X Li; Fuchun Xie; Qiuhua Fan; Kerry M Barnhart; Curtis E Moore; Arnold L Rheingold; Xiangshu Xiao
Journal:  ACS Med Chem Lett       Date:  2014-08-22       Impact factor: 4.345

10.  CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis.

Authors:  Salemiz Sandoval; Martina Pigazzi; Kathleen M Sakamoto
Journal:  Adv Hematol       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.